Our teaching programs

Prof. Dr. Jörn Lausen ,  University of Stuttgart
Gene expression control in differentiation and disease

Prof. Dr. Gustav Dobos ,  Center for Naturopathy and Integrative Medicine at the University Hospital Essen
Planetary Health Diet: Healthy eating for people and planet. What is the evidence?

Prof. Dr. André F. Martins ,  Full Professor in Advanced Preclinical Metabolic Imaging and Cell Engineering, University Hospital Tübingen
Harnessing metabolic imaging to monitor cancer aggressiveness non-invasively in vivo

PD Dr. Daniel Lipka ,  National Center for Tumor Diseases (NCT) Heidelberg & German Cancer Research Center (DKFZ)
RAS Pathway Mutations Drive Onco Fetal Reprogramming in Juvenile Myelomonocytic Leukemia

PD Dr. Frank Essmann ,  Robert Bosch Center for Tumor Diseases (RBCT) , Stuttgart
Flow cytometry and cellular imaging

Prof. Marius Ueffing , Institute for Ophthalmic Research, University Hospital Tübingen
Proteomics – From basic approaches to clinical applications

Prof. Dr. Verena Labi , Institute of Developmental Immunolog,y Medical University of Innsbruck
Roles of epigenetic TET enzymes in hematologic cancers and immunity

Sophia Steinlein ,  Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology , Stuttgart
Lymphoma associated stromal cells as an innovative therapeutic target for diffuse large B cell lymphoma

Sabrina Kalmbach , Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart
Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms

Joanna Aggrey Fynn , Robert Bosch Center for Tumor Diseases (RBCT) , Stuttgart
Regulation of Pancreatic Cancer Metastasis by Signal Conversion in the Epigenome

Prof. Dr. Sonja Loges , Medical Faculty Mannheim, Heidelberg University
Precision Oncology - from bench to bedside

Dr. Jeremy Y. Ng , Centre for Journalology , Ottawa Methods Centre, Ottawa Hospital Research Institute, Ottawa, Canada
Basic Principles in Scholarly Publishing and Open Science Practices: A Primer

Tobias Beigl , Robert Bosch Center for Tumor Diseases (RBCT) , Stuttgart
Novel insights into the transmembrane domain interactome of Bcl 2 proteins elucidated by a bimolecular split luciferase assay and it’s impact on apoptosis signalling

Prof. Dr. Steven Johnsen , Robert Bosch Center for Tumor Diseases (RBCT) , Stuttgart
Molecular cancer epigenetics

PD Dr. Frank Essmann , Robert Bosch Center for Tumor Diseases (RBCT) , Stuttgart
Apoptosis regulation and targeted therapy

Julia Thiel , Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart
Patient-derived precision-cut tumor slices as a tool to study CD3-bispecific antibody therapy in solid tumors

Prof. Dr. Lisa Maier , Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen
The consequences of drugging the gut microbiome –from the individual microbe to the host

Thomas Ekstrom , Robert Bosch Center for Tumor Diseases (RBCT) , Stuttgart
Lineage defining transcription factors regulate PDAC subtype identity through distinct mechanisms

PD Dr. Robyn Laura Kosinsky , Adj. Assis.Prof. for Medicine at Mayo Clinic, Robert Bosch Center for Tumor Diseases (RBCT)
Inflammation driven tumorigenesis

Svenja Wallisch, Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart
FORGI: Fibroblast tumor ORGanoids Immune cell co-culture – a new model to understand tumor microenvironment interactions

Prof. Markus Ketteler, MD, Robert Bosch Hospital, Stuttgart
Physiology and pathophysiology of the kidneys

Jing Yang, Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart
Research the function of hOCT1 in Drosophila melanogaster expressing hOCT1 by feeding cisplatin and cimetidine

Marcel Lackner , Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart
Establishment of Stable Isotope resolved Metabolomics as Test System to assess Membrane associated Drug Targets in Cancer

Charlotte Kölz , Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart
Functional characterization of the two liver transporters OAT2 and OAT7 through in vitro methods and two novel mouse models

Prof. Andreas Hartkopf, MD, Clinic for Gynecology and Obstetrics at the University Hospital Ulm
Physiology and pathophysiology of the breast 

Simeon Rüdesheim , Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart
Physiologically Based Pharmacokinetic Modeling to Describe and Predict the Activity Score-Dependent Metabolism of CYP2D6 Substrates

Prof. Peter Ong, MD, and Astrid Hubert, MD, Robert Bosch Hospital, Stuttgart
Physiology and pathophysiology of the cardiovascular System

Benjamin Schäfer , Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart
Potential of BCL2 Inhibition in Ovarian Cancer Therapy

Sandra Weller , Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart
ABT-199 synergizes with PI via transactivation of NOXA

Prof. Kilian Rapp, MD, Robert Bosch Hospital, Stuttgart
Grundbegriffe der Geriatrie einschließlich besonderer Aspekte der Pharmakotherapie bei gebrechlichen Menschen 

Prof. Claus Neurohr, MD, RBK Lung Center Stuttgart, Clinic Schillerhöhe GmbH
Physiology and pathophysiology of the lung

Robyn Laura Kosinsky, PhD, Robert Bosch Center of  Tumor Diseases, Stuttgart
Intestinal inflammation and tumorigenesis –Pathogenesis, molecular classification and experimental tools

Christina Schräpel , Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart
Physiologically Based Pharmacokinetic (PBPK) Modeling of Enclomiphene and its Metabolites Predicting Drug Drug Gene Interaction (DDGI) Scenarios

Prof. Marc Dahlke, MD, Robert Bosch Hospital, Stuttgart
Metastatic Disease from a Surgeons Perspective 

Tobias Beigl , Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart
Brought to light: The interaction pattern of Bcl-2 transmembrane domains in a bimolecular luciferase complementation assay

Nikolaus Lubomierski, MD, Robert Bosch Hospital, Stuttgart
Novel Classification and Treatment of Diabetes Mellitus

Sophia Steinlein , Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart
Lymphoma associated stromal cells as an innovative therapeutic target for diffuse large B cell lymphoma

Sabrina Kalmbach , Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart
Global profiling of localized and systemic forms of follicular lymphoma: the relevance of molecular features in different clinical stages

Julia Thiel , Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart
The interplay between the tumo rmicroenvironment and drug therapy in precision-cut tissue slices

Selina Maier , Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart
Anti-hormone therapy affects BKCa channel dependent K+ homeostasis in murine and human breast cancer cells

Prof. Hiltrud Brauch , Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart
How to write a paper for scientific publishing

Lena Sophie Menig , Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart
Heterogeneity of monocarboxylate transporter 1 and 4 (MCT1/MCT4) in clear cell renal cell carcinoma (ccRCC) and metastasis

Dr. Maaike van der Lee , Department of Clinical Pharmacy and Toxicology Leiden University Medical Centre
Long read sequencing and AI in pharmacogenomics

Prof. Dr. Albert Braeuning , German Federal Institute for Risk Assessment
Food safety at the German Federal Institute for Risk Assessment

Prof. Jörg Albert, MD, Robert Bosch Hospital, Stuttgart
Physiology and pathophysiology of the gastrointestinal tract

Christian Schäfer, MD, Robert Bosch Hospital, Stuttgart
Physiology and pathophysiology of the liver 

Prof. Olaf Rieß, MD, University Hospital, Tuebingen
Diagnostics of Rare Diseases: Beyond The Exome 

Prof. Uwe Fuhr, MD, University Hospital of the University of Cologne(BfR)
Pharmacokinetics

Prof. Volker Lauschke, PhD, Karolinska Institute, Stockholm
Inter-individual Differences in Drug Response - From Computational Predictions to Experimental Models 

Prof. Thomas Wider, MD, University Medical Center Tübingen
Immune Senescence Surveillance of Tumours 

Prof. German Ott, MD, Robert Bosch Hospital, Stuttgart
Diagnostic Pathology: A Method Bridging Classical Morphology and Molecular Genetics

Prof. Michael Schwarz, MD, University Hospital Tübingen
Mechanisms of Tumor Promotion  

Christina Justenhoven, PhD, Bioscientia - Institute of Medical Diagnostic GmbH, Ingelheim
Analysis of DNA variations  

Prof. Marius Üffing, PhD, University Tübingen
Proteomics - From basic approaches to clinical applications  

Prof. Albert Bräuning, PhD, German Federal Institute for Risk Assessment (BfR)
Food Safety at the German Federal Institute for Risk Assessments

Prof. Uwe Fuhr, MD, University Hospital of the University of Cologne
Pharmacokinetics - Basic Principles  

Prof. Klaus Mörike, MD, University Hospital Tübingen
Clinical Studies – Design and Realization 

Pavel Bashtrykov, PhD, University Stuttgart
Epigenetic silencing of oncogenes: a novel approach for targeted cancer therapy

Prof. Joerg Albert, MD, Robert Bosch Hospital
Physiology and pathophysiology of the digestive system

Christian Schäfer, MD, Robert Bosch Hospital
Physiology and pathophysiology of the liver  

Prof. Jun J. Yang, Ph.D., St. Jude Children's Research Hospital
Pharmacogenomics of Thiopurines and Precision Medicine: From Genomics to Clinical Actions 

Prof. Godehard Friedel, MD, Robert Bosch Hospital - Schillerhoehe
Physiology and pathophysiology of the lungs

Prof. Andreas Hartkopf, MD, University Hospital Tuebingen)
Physiology and pathophysiology of the breast

Prof. Kilian Rapp, MD, Robert Bosch Hospital
Physiological Specialties in Elderly Patients  

Prof. Peter Ong, MD, Robert Bosch Hospital
Physiology and pathophysiology of the cardiovascular System  

Prof. Robert Feil, PhD, University of Tuebingen
Seeing is believing: Combining biochemistry and mouse genetics to visualize physiology, pathophysiology and pharmacology

Martin Kimmel, MD, Robert Bosch Hospital
Physiology and pathophysiology of the kidneys

Prof. Andreas Nüssler, MD, University of Tuebingenm
Cell culture approaches towards 3D micro-organ Engineering  

Prof. Sven Glaesker, MD, University Hospital Brussels
Molecular and morphological pathogenesis in von Hippel-Lindau (VHL) disease 

Prof. Klaus Moerike, MD, University Hospital Tuebingen
Arzneimitteltherapie kardialer Arrhythmien

Prof. Robert Lukowski, PhD, University Hospital Tuebingen
The NO-cGMP system: Implications for disease biology and therapy

Reinhold Kerb, MD, CRS Clinical Research GmbHm
Drug Therapy of Diabetes, Obesity, Metabolic Syndrome  

Prof. Peter Muenzel, University of Tuebingen
Gifte und Vergiftungen  

Prof. Carsten Gruellich, MD, NCT -National Center for Tumor Diseases Heidelberg Medical Oncology
Molekulare Heterogenität und therapiegetriebene Evolution des Nierenzellkarzinoms

Markus Morkel, MD, Charité - University Hospital Berlin
Organoids as a tool to assess oncogene characteristics and cancer signaling networks

Prof. Robert Juette, PhD, Institute of the History of Medicine, Robert Bosch Stiftung
Der Placebo Effekt: Past and Present